Spravato Marketing with Provider Data
Spravato (esketamine) requires REMS certification, which limits the provider universe to a specific subset of psychiatric and mental health practices. Marketing to or for these practices requires data that distinguishes certified providers from the broader mental health market.
Updated February 2026
Why Spravato Marketing Needs Specialized Data
Spravato (esketamine nasal spray) is a controlled substance approved for treatment-resistant depression and major depressive disorder with suicidal ideation. Because of its pharmacological profile, the FDA requires it to be administered under a Risk Evaluation and Mitigation Strategy (REMS) program. Only healthcare settings that are certified under the Spravato REMS can dispense and administer the treatment.
This regulatory framework creates a very specific marketing challenge. If you're a pharmaceutical company, a medical marketing agency, or a patient referral platform, your target market isn't "all psychiatrists" or "all mental health providers." It's the subset of practices that have completed REMS certification, have the physical setup to administer Spravato (patients must be monitored for at least two hours post-administration), and are actively accepting referrals for this treatment.
The CMS NPI Registry doesn't track REMS certification. A psychiatrist's NPI record won't tell you whether they offer Spravato. Mental health provider databases don't typically include treatment-specific certifications. And the Spravato REMS provider locator, while it lists certified sites, doesn't provide the business contact data (email, phone, decision-maker) that marketing campaigns require.
The market is also changing rapidly. New practices are getting REMS-certified regularly as Spravato adoption grows and patient demand increases. A list that was current three months ago is missing newly certified sites. Conversely, some practices that obtained certification haven't actively built a Spravato program, so they're certified but not actively treating patients. Your data needs to capture both certification status and practice activity.
Who Needs Spravato Provider Data
Pharmaceutical sales teams. If you're representing Janssen or a specialty pharmacy that distributes Spravato, your reps need a complete list of certified treatment sites in their territory. Beyond the certification list, they need decision-maker contact information, practice size, patient volume indicators, and competitive intelligence about whether the site is also offering ketamine infusions as an alternative.
Marketing agencies. Agencies that help Spravato-certified practices attract patients need to identify the practices first. Some agencies specialize in mental health marketing and want to build a pipeline of potential clients. Others are already working with a few Spravato practices and want to expand to similar sites in new markets. In both cases, the agency needs practice-level data with business contact information.
Patient referral platforms. Digital health platforms that connect patients with treatment-resistant depression to Spravato providers need verified location data, hours, contact information, and potentially insurance acceptance details. The data needs to be patient-facing accurate: the address should be where the patient shows up, not a billing address.
Ancillary product and service vendors. Companies selling monitoring equipment, recliner chairs for the observation period, scheduling software for treatment session management, or specialty pharmacy services to Spravato practices need to find these practices and reach the operational decision-maker.
What Good Spravato Provider Data Includes
REMS certification indicator. The most important field is whether a practice has completed the Spravato REMS certification process. This is the binary filter that separates potential Spravato sites from the broader mental health market.
Practice type and setting. Spravato is administered in psychiatric practices, ketamine clinics, outpatient mental health centers, and hospital-based psychiatry departments. Each setting has different decision-making processes, different physical infrastructure, and different marketing channels. A private psychiatric practice with a Spravato program is a different prospect than a hospital outpatient department offering Spravato as one of many treatment options.
Decision-maker identification. In a private psychiatric practice, the prescribing psychiatrist is often the owner and decision-maker. In a larger mental health organization, there may be a clinical director, an operations manager, or a program coordinator who manages the Spravato program specifically. Your outreach should target the person who controls referral partnerships, equipment purchases, and vendor relationships.
Ketamine program overlap. Many practices that offer Spravato also offer ketamine infusion therapy (off-label IV ketamine). Knowing whether a practice offers both, or only one, helps you position your product or service relative to the practice's existing treatment menu. This overlap data is also useful for pharmaceutical companies tracking competitive treatment alternatives.
Verified contact details. Business email, direct phone, and practice address verified for accuracy. For a market growing as quickly as Spravato treatment centers, contact data from even six months ago may not reflect current practice details.
How Provyx Supports Spravato Market Outreach
Provyx builds Spravato-focused provider lists by combining NPI Registry data for psychiatrists and mental health providers with REMS certification intelligence, practice-level data, and verified business contacts. We identify practices that have the certification, the infrastructure, and the active patient-facing presence that indicates they're running a Spravato program, not just holding a dormant certification.
Every record includes the practice name, prescribing provider details, decision-maker identification, verified email, phone, practice address, and available indicators of treatment program activity. For practices that also offer ketamine infusion therapy, we flag the overlap.
Geographic filtering lets pharma reps target their assigned territory, marketing agencies identify prospects in their service area, and referral platforms build location-based directories. We can deliver national lists or territory-specific segments.
Given the rapid growth of Spravato adoption, we recommend quarterly list refreshes to capture newly certified sites and updated contact information. The data arrives in CSV or Excel format for direct CRM or marketing platform import.
Frequently Asked Questions
How many Spravato-certified treatment centers are in the US?
The number of certified sites grows as adoption increases. As of early 2026, there are several thousand REMS-certified locations across the US, including private psychiatric practices, ketamine/Spravato specialty clinics, and hospital-based programs. The exact count fluctuates as new sites complete certification.
Can you separate Spravato-only providers from practices that also offer ketamine infusions?
Yes. We flag practices that offer Spravato only, ketamine infusions only, or both treatments. This distinction is useful for pharmaceutical companies tracking competitive positioning and for marketing agencies tailoring their messaging.
Do you include hospital-based Spravato programs?
Yes. Our data includes Spravato programs in hospital outpatient departments, academic medical centers, and VA facilities alongside private practice sites. Hospital-based programs are identified with the institutional affiliation and department-level contact information where available.
How current is Spravato certification data?
We update certification data regularly to capture newly certified sites. Because new practices are completing REMS certification on an ongoing basis, we recommend refreshing your list quarterly. Each update includes new certifications and any changes in contact details for previously certified sites.
Sources and References
Related Resources
Get the Provider Data You Need
Tell us what you're looking for. We'll build a custom list matched to your target market.
Trusted by healthcare sales teams, medical device companies, and health IT vendors across the US.